Diabetic retinopathy is one of the most common causes of vision impairment and blindness among adults worldwide. It is a progressive microvascular complication of diabetes that affects the blood vessels of the retina. Long-standing high blood sugar levels damage the retinal capillaries, leading to leakage, reduced oxygen supply, inflammation, and abnormal new blood vessel formation. Over time, these changes result in structural and functional damage to the retina.
In the early stages, known as non-proliferative diabetic retinopathy, patients may not experience noticeable symptoms. As the disease progresses, symptoms such as blurred vision, fluctuating visual clarity, dark spots, floaters, and difficulty seeing at night may appear. In advanced stages, called proliferative diabetic retinopathy, fragile new blood vessels grow on the retina and vitreous, increasing the risk of retinal bleeding, scar tissue formation, retinal detachment, and permanent vision loss.
Diabetic retinopathy is closely linked to poor glycemic control, long duration of diabetes, hypertension, high cholesterol, kidney disease, and smoking. Conventional treatment options include laser photocoagulation, intravitreal anti-VEGF injections, corticosteroid therapy, and vitrectomy surgery. These treatments help control disease progression and manage complications, but they do not restore damaged retinal tissue or reverse neural degeneration.
Stem cell therapy offers a regenerative approach for diabetic retinopathy by targeting both vascular damage and neural dysfunction. At Stem Cell Cure India, advanced regenerative protocols are designed to support retinal repair, improve microvascular circulation, and reduce chronic inflammation. Stem cells release growth factors and bioactive molecules that promote tissue healing, stabilize blood vessel integrity, and enhance retinal metabolism.
The therapeutic strategy focuses on neurovascular regeneration, which involves protecting retinal neurons while improving blood flow and oxygen supply. This dual action may help slow disease progression, reduce retinal edema, and improve functional vision in selected patients.
Before initiating therapy, patients undergo comprehensive evaluation including fundus examination, optical coherence tomography (OCT), fundus fluorescein angiography (FFA), visual acuity testing, and systemic medical assessment. Blood sugar control, blood pressure, kidney function, and cardiovascular status are carefully reviewed to ensure treatment safety and effectiveness.
At Stem Cell Cure India, treatment for diabetic retinopathy is personalized based on disease stage, severity, duration of diabetes, and overall systemic health. Regenerative therapy is often integrated with ongoing diabetic management to achieve optimal outcomes.
Stem cell therapy for diabetic retinopathy represents an advanced supportive option for patients who continue to experience visual decline despite conventional treatments. By focusing on retinal regeneration, vascular repair, and inflammation control, Stem Cell Cure India provides a scientifically guided and ethically supervised approach aimed at preserving vision, improving retinal function, and enhancing long-term quality of life for individuals living with diabetic eye disease.
A diabetes-related condition that damages retinal blood vessels.
Blurred vision, floaters, and dark spots.
They may promote vascular repair and reduce inflammation.
Early stages may improve; advanced stages are often permanent.
Yes, with good blood sugar control.
